Robert Hershberg is Director of FATE THERAPEUTICS INC. Currently has a direct ownership of 10,659 shares of FATE, which is worth approximately $24,409. The most recent transaction as insider was on Jun 09, 2022, when has been sold 8,650 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K
0% 3M change
0% 12M change
Total Value Held $24,409

ROBERT HERSHBERG Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2022
BUY
Grant, award, or other acquisition
-
8,650 Added 44.8%
10,659 Common Stock
Jun 03 2022
SELL
Open market or private sale
$15,288 $22.75 p/Share
672 Reduced 25.07%
2,009 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
2,681 Added 50.0%
2,681 Common Stock

Also insider at

ADPT
Adaptive Biotechnologies Corp Healthcare
NSTG
NanoString Technologies Inc Healthcare
SBTX
Silverback Therapeutics, Inc. Healthcare
RXRX
RECURSION PHARMACEUTICALS, INC. Healthcare
HLVX
HilleVax, Inc. Healthcare
RH

Robert Hershberg

Director
San Diego, CA

Track Institutional and Insider Activities on FATE

Follow FATE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

News

Receive news related to FATE THERAPEUTICS INC

Track Activities on FATE